Company Statement: Teva and Cephalon receive European Commission approval for acquisition
MLex Summary: Teva has announced it expects its merger with Cephalon to close by October 14, upon receiving the last necessary approval today from the European Commission.Company statement follows in full:...To view the full article, register now.
Already a subscriber? Click here to view full article